Multiple sclerosis (MS) impacts over 2 million people around the world, costs economies billions of dollars, and degrades the quality of life of sufferers. Many of the disease's most significant impacts are hidden, including pain, fatigue, mood changes, and impaired mobility. The lack of visible signs of MS can often lead to misperceptions, misunderstandings, and stigma. Thus, when developing new treatments, a patient-centric approach that takes these hidden symptoms into account is essential. This is the ultimate goal at Janssen: a holistic approach to patient well-being through treatments that address both the hard and hidden symptoms of MS.